SCHEMBL11247614

SCHEMBL11247614

CCOC(=O)CCc1ccc(N)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.56
CYP4A11 Q02928 2/20 0.56
CYP4Z1 Q86W10 2/20 0.46
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
P2RY12 Q9H244 1/20 0.44
APP P05067 2/20 0.43
CYP1A2 P05177 1/20 0.41
EPHX2 P34913 1/20 0.40
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
KCNQ4 P56696 1/20 0.40
KCNQ5 Q9NR82 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PPIB P23284 1/20 0.39
PPIA P62937 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7256065 0.99 CYP4F2 (0.55) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL6985238 0.90 CYP4F2 (0.58) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
Hydrochloric Acid SCHEMBL6982842 0.88 CYP4F2 (0.56) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL6913578 0.86 CYP4F2 (0.61) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL3862461 0.86 CYP4F2 (0.61) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL8257852 0.85 CYP4F2 (0.59) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL3446879 0.85 ALDH1A1 (0.45) ALDH1A1
SCHEMBL9606643 0.85 ALDH1A1 (0.45) CYP4F2CYP4A11CYP4Z1KCNQ3KCNQ2
SCHEMBL13263723 0.85 CYP4F2 (0.59) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL2347025 0.84 CYP4F2 (0.58) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105601504-B A kind of preparation method of 2 (xenyl of 2 fluorine 4) propionic acid 郑州西格玛化工有限公司 2018-01-09 CN disclosed
WO-2009119776-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF 武田薬品工業株式会社 (JP) 2009-10-01 WO disclosed
US-4333940-A Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development AMERICAN CYANAMID COMPANY (US) 1982-06-08 US disclosed
US-4243609-A ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1981-01-06 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed